{"id":"NCT00759148","sponsor":"Alcon Research","briefTitle":"Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-10","primaryCompletion":"2010-03","completion":"2010-03","firstPosted":"2008-09-25","resultsPosted":"2011-03-22","lastUpdate":"2018-01-02"},"enrollment":1179,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bacterial Conjunctivitis"],"interventions":[{"type":"DRUG","name":"Moxifloxacin Alternative Formulation (AF) Ophthalmic Solution 0.5%","otherNames":[]},{"type":"OTHER","name":"Moxifloxacin AF Vehicle","otherNames":[]}],"arms":[{"label":"Moxifloxacin AF","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of Moxifloxacin AF Ophthalmic Solution compared to Moxifloxacin AF Vehicle in the treatment of bacterial conjunctivitis in patients one month of age or older.","primaryOutcome":{"measure":"Clinical Cure at the Day 4 (EOT)/Exit Visit","timeFrame":"Day 4","effectByArm":[{"arm":"Moxifloxacin AF","deltaMin":62.5,"sd":null},{"arm":"Vehicle","deltaMin":50.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21681652"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":593},"commonTop":[]}}